236 articles 4 sections last published 2026-08-31 independent · no sponsored placements

Fund index

PAVE

8 articles on this site analyse PAVE — 2 of them head-on.

Measured concentration

as of 2026-05-31
101 Holdings (nominal)
50.6 Effective holdings
Overstatement
32.32% Top 10 weight

PAVE reports 101 positions, but the weights make it behave like about 50.6 equally weighted ones. Computed by this site from the fund's SEC Form N-PORT filing — see what this measure does not tell you and the full table.

The same filing says what kind of price those positions carry: 100% of PAVE is held at a quoted market price, from a single issuer country . Comparisons across every fund are in the valuation table, and what a low share does and does not mean is worth reading before drawing a conclusion from it.

Every filing since 2019

27

Between 2019-11-30 and 2026-05-31, PAVE went from behaving like 48.5 equally weighted positions to 50.6 — 4% more, while its top ten went from 32.65% to 32.32% of net assets. Read across the funds on the concentration-over-time table.

PeriodHoldingsEffective Top 10Largest
2026-05-31 101 50.6 32.32% 4.18%
2026-02-28 101 50.9 32.42% 3.39%
2025-11-30 100 50.1 32.56% 4.39%
2025-08-31 100 50.4 32.41% 3.89%
2025-05-31 103 49.9 32.51% 4.21%
2025-02-28 102 51.4 31.99% 3.49%
2024-11-30 101 53 31.99% 3.69%
2024-08-31 99 52.9 31.18% 3.71%
2024-05-31 100 53.8 30.68% 3.61%
2024-02-29 99 52.1 30.44% 3.25%
2023-11-30 98 51.1 31.87% 3.86%
2023-08-31 98 52 31.22% 3.81%
2023-05-31 100 52.4 30.45% 3.43%
2023-02-28 98 53.2 30.71% 3.44%
2022-11-30 100 51.9 30.94% 4.54%
2022-08-31 101 52.3 30.56% 4.37%
2022-05-31 101 53 30.44% 4.33%
2022-02-28 102 53.9 30.23% 4.14%
2021-11-30 101 52.2 30.29% 3.5%
2021-08-31 98 51.4 30.95% 3.87%
2021-05-31 100 52.8 29.94% 3.44%
2021-02-28 101 53.5 29.92% 3.33%
2020-11-30 94 48.2 32.6% 3.82%
2020-08-31 93 45.6 34.35% 4.3%
2020-05-31 94 46.3 33.71% 4.17%
2020-02-29 94 48.6 31.35% 3.39%
2019-11-30 93 48.5 32.65% 3.76%

One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.

Most often compared against

4

Measures applied to it

8

All articles

8

Mentions are detected across the full text of every article, so an appearance may be a passing comparison rather than the subject. Nothing here is a recommendation to buy or sell — see the disclaimer.